Nouveauté

Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone

E. KELTY ; G. HULSE | 2017
Dans International Journal of Drug Policy (Vol.46, August 2017) Article : Périodique

Background: Illicit opioid use is associated with high rates of fatal and non-fatal opioid overdose. This study aims to compare rates of fatal and serious but non-fatal opioid overdose in opioid dependent patients treated with methadone, bupreno[...]

Plus d'info

Ajouter à la sélection

Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants

JEFFREY G. P. ; MACQUILLAN G. ; CHUA F. ; GALHENAGE S. ; BULL J. ; E. YOUNG ; G. HULSE ; G. O'NEIL | 2007
Périodique

ENGLISH : The effectiveness of HCV antiviral therapy in patients who have undergone recent drug dependency treatment and continue to inject drugs sporadically is presently not clear. Patients attending a community-based drug rehabilitation and[...]

Plus d'info

Ajouter à la sélection

The quantification of morbidity and mortality caused by substance abuse. Prepared for the Second International Symposium on the Social and Economic Costs of Substance Abuse, 2-5 October 1995

D. R. ENGLISH ; C. D'ARCY ; HOLMAN J. ; E. MILNE ; G. HULSE ; M. G. WINTER | 1995
Congrès

In this paper we identify the major issues in attributing mortality and morbidity to substance abuse, review studies of the quantification of morbidity and mortality due to substance abuse and discuss guidelines for choosing the most appropriate[...]

Plus d'info

Ajouter à la sélection